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Abstract
Chemotherapy  induced-hepatotoxicity  is  one  of  the  prevalent  problems  among  cancer
patients, with a wide spectrum of complications from liver dysfunction to liver necrosis.
Therefore, in this study, we review the research findings on the effects of medicinal herbs
and  herbal  compounds  on the  hepatotoxicity  induced by  anticancer  drugs.  The words
hepatotoxicity and hepatoprotective along with the words cancer drug or chemotherapy in
combination with some herbal terms such as medicinal plant, phyto* and herb* were used
to search for relevant publications indexed in the  Institute for Scientific Information (ISI)
and  PubMed.  Available  evidence  shows  that  certain  medicinal  plants  and  herbal
derivatives can reduce cancer drug-induced hepatotoxicity and protect liver cells against
complications by regulating hepatic enzymes and increasing antioxidant enzyme activities.
Some herbal formulations, including traditional Chinese medicine, have also been reported
to exhibit such effects.  Medicinal  plants can exert anti-hepatotoxicity effects  mainly by
increasing  antioxidant  activity,  inhibiting  inflammatory  processes,  and  reducing  cell
necrosis  induced  by  anti-cancer  drugs.  Phytotherapy  can  be  used  as  an  effective
complementary treatment for anticancer drug-induced hepatotoxicity and prevent various
complications in the liver.
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Introduction
With  the  spread  of  industrialization,  cancers  are
one of the major causes of death in the world, with
approximately 14 million new cases and 8.2 million
cancer-associated  deaths  in  2012  (1).  Anticancer
drugs  may  cause  hepatotoxicity  alone  or  due  to
interaction with other drugs, which is transient in
some  cases,  or  leads  to  liver  tissue  damage  and
threatens the life of the individual  in  other cases
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(2,3).  Certain  classes  of  chemotherapeutic  agents
such  as  alkylating  agents,  anti-metabolites,  anti-
tumor antibiotics, isomerase inhibitors and mitotic
inhibitors, hormone therapy and immunotherapy
cause  hepatotoxicity  (2).  Sinusoidal  obstructive
syndrome  (SOS),  steatosis,  pseudocirrhosis,  acute
hepatitis and necrosis are conditions that correlate
with liver abnormalities in patients being treated
with chemotherapy and lead to abnormal liver test
results  (4,5).  However,  the  hepatotoxicity
mechanism is still unclear (5). Although the use of
hepatoprotective agents in oncology is beneficial,
no  documented  evidence  exists  for  their  clinical
use  (6). Traditional and complementary medicine
(TCM)  approaches  (Such  as  aromatherapy,
hypnotherapy,  yoga,  massage  therapy,  use  of
medicinal  plants,  etc.)  have  been  used  to
prevention  and  treatment  diseases  (7-13),  where
the  herbal-based  medicines  were  the  most
commonly  used form of  TCM (14-20).  They  have
little to no  side  effects  compared  with  synthesis
drugs. Various studies have shown that medicinal
herbs can be effective, inexpensive,  and efficient
treatments for various diseases, including against
toxicity  (21-30).  Hepatoprotective  agents  seem to
be useful in the oncologic setting, yet they are still
not  widely  documented  for  clinical  usage  (6).
Therefore,  this  article  reviews  research  findings
on  the  effects  of  medicinal  plants  and  plant
compounds  on  anticancer  drug-induced
hepatotoxicity.
Search strategies
The  key words  of  interest  and  Endnote software
were used to conduct this review. The key words
hepatotoxicity and hepatoprotective along with the
words  cancer  drug or  chemotherapy in
combination  with  some  herbal  terms  such  as
medicinal  plant,  phyto*,  and  herb*  were  used  to
search  for  relevant  publications  indexed  in  the
Institute  for  Scientific  Information  (ISI) and
PubMed with EndNote software (Table 1).
A  standard  form  was  designed,  which
included items such as aim or the title of the study,
intervention,  outcome,  variables,  journal  name,
period,  and  number.  The  article’s  contents  that
were relevant to this study were recorded on the
form and entered into the study upon agreement
of the researchers involved in this study. Then the
plants  and  the  plant-based  products  that  were
reported  to  be  effective  to  treat  or  reduce
symptoms  of  cancer  drug-induced  hepatotoxicity
were selected.  The articles whose full  texts were
not  accessible,  studies  with  non-positive  effects,
non-English language articles, review articles, and
studies that were not related to the purpose of this
study were excluded after all  researchers in this
study  agreement  was  achieved.  Fig.  1  illustrates
how the articles were selected for final analysis.
Table 1: Number of studies divided by database
Hepatotoxicity+ cancer drug+ medicinal 
plant
PubMed 14
ISI 17
Hepatotoxicity+ cancer drug+phyto*
PubMed 31
ISI 20
Hepatotoxicity+ cancer drug+herb*
PubMed 35
ISI 47
Hepatotoxicity+ chemotherapy + 
medicinal plant
PubMed 4
ISI 4
Hepatotoxicity+ chemotherapy + phyto*
PubMed 10
ISI 5
Hepatotoxicity+ chemotherapy + herb*
PubMed 10
ISI 16
Hepatoprotective + cancer drug+ 
medicinal plant
PubMed 40
ISI 34
Hepatoprotective + cancer drug+ phyto*
PubMed 60
ISI 29
Hepatoprotective + cancer drug+ herb*
PubMed 39
ISI 36
Hepatoprotective + chemotherapy + 
medicinal plant
PubMed 4
ISI 3
Hepatoprotective + chemotherapy + 
phyto*
PubMed 4
ISI 4
Hepatoprotective + chemotherapy + herb*
PubMed 6
ISI 6
Total
PubMed 257
ISI 221
Fig. 1. Flowchart of the process of selecting the articles for final
analysis
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Table 2: Medicinal plants that have an effect on cancer drug-induced hepatotoxicity
Main effects or mechanismsType ofadministrationStudy Design
Cancer drug /
treatment-inducing the
hepatotoxicity
PlantsReferences
Protective effect against mitochondrial
dysfunction induced by co-administration of
cisplatin and cyclophosphamide and did not
show any significant changes on
mitochondrial membrane bioenergetics
Aqueous extractExperimental (invivo)
Cisplatin and
cyclophosphamide
Phyllanthus
fraternus
Kumari et al.
(31)
Reducing oxidative stress in liver by
decreasing malondialdehyde and nitric oxide
and improving glutathione content and
glutathione-S-transferase, glutathione
peroxidase (GPx), catalase, and superoxide
dismutase activities.
Methanolic neem
leaves extract
Experimental (in
vivo)Cisplatin
Azadirachta
indicaDkhil et al.(32)
Mitigating cyclophosphamide-induced
oxidative stress and reversing expression of
genes for  antioxidant enzymes.
Aqueous extractExperimental (invivo)Cyclophosphamide
Decalepis
hamiltonii
Zarei and
Shivanandap
pa
(33)
Decreasing plasma malondialdehyde and
increasing the superoxide dismutase and
glutathione because less use of antioxidant
compounds may not affect the production
and control of oxidative metabolites, or on
the other hand, the excessive use of these
plants and their compounds has adverse
effects on the anticancer and apoptotic effects
of anticancer drugs, oxidase (GSH-PX) levels
and GSH-PX/MDA ratio
Pu-erh tea powderExperimental (invivo)Cisplatin
Camellia
sinensis
Zheng et al.
(34)
Reducing cisplatin-induced hepatic
inflammation and cell death.Aqueous extract
Experimental (in
vivo)Cisplatin
Antrodia
cinnamomea
Huang et al.
(35)
Causing a decrease in aspartate
aminotransferase, alanine
aminotransferase, and peroxidation as
well as an increase in the level of
endogenous antioxidants such as
glutathione and glutathione reductase
Methanolic extractExperimental (invivo)Cyclophosphamide
Curcuma
caesia Roxb.
Devi and
Mazumder
(36)
Lowering level of aspartate
aminotransferase and lipid profile and
minimizing the histological damage 
Methanolic extractExperimental (invivo)Cyclophosphamide
Rosmarinus
officianalis
El-Naggar et
al. (37)
Protecting DNAOilExperimental (invivo)CyclophosphamideNigella sativaTuorkey (38)
Reducing serum levels of Aspartate
aminotransferase (AST) and Alanine
Aminotransferase (ALT) after
chemotherapy
Capsule contain
powderClinical trial
Methotrexate,
Mercaptopurine and
Vincristine
Silybum maria
numLadas (39)
Returning serum levels of AST and ALT
after chemotherapy and Anaplastic
lymphoma kinase (ALK) to the baseline
before start of chemotherapy
ExtractCase- reportDaunorubicin andcytarabine
Silybum maria
num
McBride et al.
(40)
Inhibition of lipid peroxidation and
augmentation of endogenous
antioxidants
Aqueous extractExperimental (invivo)Cyclophosphamide
Phyllanthus
fraternusLata et al. (41)
Reducing the level of AST, ALT and ALP
serum activity;inhibiting lipid
peroxidation and protein
carbonylation;restoring antioxidant
enzymes (SOD, CAT, and GSH-Px);
elevating glutathione level
Methanolic extractExperimental (invivo)Cisplatin
Zataria
Multiflora
Boiss
Ahmadipour
et al. (42)
Reducing activity of AST, ALT, ALP and
LDHEthanolic extract
Experimental (in
vivo)MethotrexateMorus nigraTag et al. (43)
Reversing GSH metabolism and primary
bile acids synthesis and NRF 2, one of the
regulatory elements of the expression of
GCLC, GCLM, GS, GST, NTCP and MRP3
Compounds,
including
ginsenoside
Experimental (in
vivo)CyclophosphamidePanax (Ginseng)Zhu et al. (44)
Inhibiting lipid peroxidation, and
increasing enzymatic defense system
(SOD, CAT, GPx) against oxidative stress. 
Aqueous extractExperimental (invivo)Cyclophosphamide
Marrubium
vulgare
Ettaya et al.
(45)
Restoring antioxidant enzymes (SOD,
CAT, GR, GST, and GPx)Essential oils
Experimental (in
vivo)Cyclophosphamide
Foeniculum
vulgare
Sheweita et al.
(46)
Increasing serum activities of oxidative stress
markers (SOD, CAT, GPx and GSH) and
decreasing lipid peroxidation
Kernel oilExperimental (invivo)MethotrexateCocos nucifera
Famurewa et
al. (47)
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Medicinal  plants,  compounds and derivatives
that effect cancer drug-induced hepatotoxicity
Plants  can  help  reduce  hepatotoxicity  through
various mechanisms (Table 2).
There are numerous plant compounds for
the  treatment  of  chemotherapy-induced
nephrotoxicity  in  patients  that,  in  addition  to
protecting  the  liver  against  toxic  substances,
prevent necrosis  as  well.  Plants  can help reduce
hepatotoxicity through various mechanisms (Table
3).
Mechanisms  of  hepatoprotective  and  anti-
hepatotoxicity properties of medicinal herbs
Phytochemicals  can  exert  their  hepatoprotective
properties through essential oils, phenyl compounds,
monoterpenoids, coumarins, diterpenoids, alkaloids,
triterpenoids, steroids, and others. These compounds
inhibit oxidative stress-inducing agents,  damage to
proteins  and  DNA,  and  lipid  peroxidation,  and
therefore  lead  to  the  formation  of  highly
immunogenic  molecules,  amplification  of  the
inflammatory  response,  and induction  of  necro-
apoptosis  of  hepatocytes.  Reactive  oxygen  species
(ROS) also contributes to the production of the TGF-
β pro-fibrogenic mediator from Kupffer cells and the
circulating  inflammatory  cells  and  activates
hepatic stellate cells directly, which triggers fibrosis
(63).  In  addition  to  protecting  the  liver  against
anticancer  drugs,  medicinal  plants  and  plant
compounds can also protect the liver against other
drugs  (64,65) and  toxic  substances  (66-69) by
exerting  their  antioxidant  activity.   These  natural
treatments  can  also  exert  anticancer  effects
themselves by inducing growth arrest and triggering
pro-apoptotic death in liver cells  (70). Some plants,
such  as  Lindera  obtusiloba,  help  protect  the  liver
through the IGF-1 and NFκB signaling pathways by
inhibiting  critical  receptor  tyrosine  kinases  that
contribute  to  the  progression  of  human
hepatocellular  carcinoma  (71).  In  addition,
treatment with phytoestrogen prevents increase in
levels  of  malondialdehyde,  nitric  oxide,  ALT,  and
AST,  and  increases  the  activity  of  superoxide
dismutase (SOD), glutathione peroxidase (GPx), and
catalase. It also increases levels of glutathione (GSH)
and  glutathione reductase  (GR).  Through  such
mechanisms,  they  protect  against  mitochondrial
damage  and  cell  apoptosis  (32,36,  72,73).  Some
medicinal  plants  also  exhibit  anti-nephrotoxicity
properties  by  inhibiting  inflammatory  processes
(decreasing  NFκB-mediated  hepatic  inflammation)
and decreasing cell necrosis (35,74).
At the cellular level, it can be argued that
mitochondrial  damage  is  one  of  the  most
significant  consequences  due  to  the  increase  of
ROS  in  chemotherapy,  which  occurs  due  to
structural  changes,  increased  mitochondrial
permeability,  and  reduced  mitochondria
membrane,  which  then  disrupts  normal  cell
function  (75). But despite the protective and anti-
necrotic  properties,  certain  medicinal  plants  or
their  derivatives  at  high  doses  can  cause
cytotoxicity in liver cells (76,77), and in some cases,
herbal self-care is used for treating these toxicities
(78). Therefore, the use of medicinal plants should
be  supervised  by  a  specialist  and  physician  and
special measures should be taken for patients with
liver disease. 
Complications  and  limitations  of  medicinal
herb use with chemotherapy
Anticancer  drugs  have  major  adverse  effects
through oxidative stress  pathways,  inflammatory
processes,  and  cell  apoptosis.  Plants  and  their
derivatives  mainly  protect  the  liver  against  free
radicals and inflammatory cytokines. 
They  can  also  induce  their  properties  by
increasing  the  content  of  glutathione  and
modulating various signal transduction pathways
(79). However, it should be noted that the use of
antioxidants and even some herbal extracts for the
prevention  and  reduction  of  tissue  toxicities
should be supervised by a physician, and that they
should be taken with caution (80).  Because studies
show that polyphenols in green tea (as a plant with
high  antioxidant  properties)  and  alkaloids  and
aristolochic  acids  in  some  plants  can  cause
inflammation and nephrotoxicity, these can cause
liver  dysfunction  and  apoptosis  of  normal  liver
cells  (81-84).  However,  because  of  the numerous
side  effects  of  anticancer  drugs  such  as
hepatotoxicity,  bone  marrow  suppression,  and
nephrotoxicity,  it  is  necessary  to  seek  out
alternative  anti-cancer  methods.  This  alternative
method  can  be  use  of  herbal  (85)  or  chemical
drugs.   However,  the  use  of  antioxidant
compounds with anticancer drugs is still debatable
because some studies suggest that excessive use of
antioxidant  compounds  can  interfere  with  the
process  of  chemotherapy  and  cancer  treatment
(86). Other studies have demonstrated the beneficial
effects of antioxidants and a decrease in damage to
normal cells and complications of chemotherapy by
these  compounds  (87).  Even  so,  interaction  of
anticancer drugs with herbal drugs can cause severe
impairments  in  the  patient  that  cause  certain
problems in the treatment process and the immune
system,  including  nausea  and  vomiting,  alopecia,
fatigue,  inflammation,  peripheral  neuropathy  and
pain (88), and even in some cases, hepatotoxicity in
cancer patients  (89). In addition, herbal medication
constituents that exert hepatoprotective activity are
poorly absorbed after oral administration; methods
that  can  improve  their  bioavailability  must  be
developed and active plants must be isolated (63).  It
is essential to determine the optimal effective dosage
without toxicity in the use of these drugs, because
small  amounts of antioxidant compounds may not
affect  the  production  and  control  of  oxidative
metabolites, while excessive use of these plants and
their  compounds  has  adverse  effects  on  the
anticancer  and anti-apoptotic  effects  of  anticancer
drugs.
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Table  3: Medicinal plant compounds and derivatives shown to have an effect on cancer drug-induced hepatotoxicity
Medicinal plants compounds 
Main effects or mechanismsType ofadministrationStudy Design
Cancer drugs that induced
hepatotoxicityHerbal compounds / derivativesReferences
Have protective effect by
reducing serum levels of AST
and ALT after chemotherapy
Extracts in the
form
of powders
Case-control
Ara-C, bleomycin, carboplatin,
cisplatin, cyclophosphamide,
dacarbazine, doxorubicin,
etoposide, fluorouracil,
formoxol, gemcitabine,
ifosfamide, mitoxantrone,
methotrexate, mitomycin
C, oxaliplatin, taxol and
taxotere (with potential
hepatotoxicity); arimidex,CPT-
11, faslodex, herceptin,
navelbine, tamoxifen, UFUR
Traditional Chinese medicine
composed of Xiao-Chai-HuTang,
Huang-Lian-Jie-Du-Tang or Yin-
Chen-Wu-Ling-San
Liu et al. (48)
Exert its hepatoprotective
properties by regulating AST
and AST
PowderExperimental (invivo)Cyclophosphamide
Vivartana composed of Cassia
auriculata (leaves), Syzygium
cumini (seed coat), Thespesia
populnea (bark), Piper longum
(dried fruit)
Gnanasekar
an  et al. (49)
Prevented the elevation of the
ALT and AST levels as well as
the reduction of total
glutathione (T-GSH), GSH, and
glutathione S-transferase (GST)
Ethanolic extractExperimental (invivo)Cisplatin
Chinese ZengmianYiliu granule
composed of Radix Astragali
Mongolic, Radix Codonopsis,
Radix Rehmanniae, Herba
Scutellariae Barbatae, Rhizoma
Atractylodis Macrocephalae
Gong et al.
(50)
Attenuated SOD and GSH
elevated levels; inhibit
apoptosis by reducing cleaved
caspase-3 expression
Aqueous ExtractExperimental (invitro)Cyclophosphamide
Haoqin Qingdan consist of
Artemisinin,bambooshavings,
Pinellia ternata, Indian buead,
Scutellaria baicalensis, Auran-
tii fructus, Aurantii nobilis
pericarpium, and Biyu powder
Li et al. (51)
Medicinal plants compounds’ derivatives
Led to activation of catalase
and GSH-S-transferase by
increasing antioxidant defense,
such as elevating the level of
GSH
Herbal
derivative
Experimental (in
vivo)CyclophosphamideGallic acid
Oyagbemi et
al. (52)
Ameliorated against the
decrease in SOD,catalase and
GST activities. Also has
antioxidant activity
Herbal
derivative
Experimental (in
vivo)CyclophosphamideGallic acid
Olayinka
(53)
Inhibiting the PI3K/Akt /NF-kB
pathway through 4T1-tumor
bearing mice
Herbal
derivative
Experimental (in
vivo)EpirubicinPaeonol
Wu et al.
(54)
The antioxidant proteins
associated with the Nrf2
signaling pathway in mice
increased
Ginsing extractExperimental (invivo)CisplatinGinsenoside Rg1
Gao et al.
(55)
Reversed changes in liver
where most hepatocytes
appeared diminutive with
vacuolated cytoplasm, dilated
sinusoids and organelle
disorganization
Herbal
derivative
Experimental (in
vivo)CisplatinSilymarin
Abdelmegui
d et al. (56)
Reducing the level of ALT and
AST and alkaline phosphatase
Herbal
derivativeClinical trialMethotrexateSilymarin
Hagag et al.
(57)
Hepatic ascorbic acid, GSH,
glutathione-S-transferase, SOD,
and catalase activities
decreased; reestablished
hepatic antioxidant status and
lipid peroxidation
Herbal
derivative
Experimental (in
vivo)MelphalanQuercetin
Olayinka et
al. (58)
Reduced immunopositivity for
the apoptosis marker caspase-3
Herbal
derivative
Experimental (in
vivo)Oxaliplatin
Resveratrol, rutin, quercetin, and
quercetin nanoemulsion
Schwingel et
al. (49)
Serum ALT, MDA and AST
level were decreased.
Herbal
derivative
Experimental (in
vivo)OxaliplatinGlutathioneLin et al. (60)
Serum levels of AST, MDA and
ALT decreased and GSH level
as well as GPx activity
increased
Herbal
derivative
Experimental (in
vivo)MethotrexateBerberine
Mehrzadi et
al. (61)
Restoration of hepatic markers,
amelioration of lipid profile,
and improvement of
antioxidant status and DNA
damage
Zingiber
officinale
derivative 
Experimental (in
vivo)CyclophosphamideZingerone
Mir  et al.
(62)
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Conclusion
Phytotherapy  can  be  used  as  an  effective  and
efficient  approach  to  treat  hepatotoxicity  caused
by  anticancer  drugs,  and  prevent  several
complications  in  the  liver.  Plants  and  their
compounds and derivatives can protect  the liver
against  anticancer  drugs  and  are  used  as  an
alternative to chemical treatments mainly due to
their  antioxidant  and  anti-inflammatory
properties. 
However,  it  is  necessary  to  develop
evidence based on human studies to obtain more
reliable results regarding the safety and efficacy of
herbal  drugs in the chemotherapy process. More
research must be done to accurately determine the
safety  and  efficacy  of  potential  herb–drug
interactions upon concurrent administration.
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